another editorial by Wilkin

[Guest guest]

Here is another, more recent 1999 editorial by Jonathon Wilkin. It

discusses the use of topicals to maintain remission:

http://archderm.ama-assn.org/issues/v135n1/fpdf/ded8021.pdf

Again, the derm literature is a bit weird. Only here can someone

(Wilkin) totally trash someone else's study (in this case, Mark Dahl,

who, like Wilkin, is a prominent rosacea researcher an member of the

National cea Society advisory board) in an editorial (as opposed

to letter to the editor), with no opportunity for the criticized

party to respond.

Second, note that Wilkin carefully inquires of his patients which

season is typically " best " for their rosacea (summer seems to be the

most popular choice), and then deliberately starts the remission

program to coincide with what would otherwise be the most benign

period for each patient. Assuming he followed this statitically

biased approach in his 1994 editorial (where he bragged about his

superior success rate in weaning patients off of systemic anitbiotics

to topicals), it certainly raises questions about the conduct of his

studies (and his rather remarkable ego.)

Rick

[Guest guest]

Here is another, more recent 1999 editorial by Jonathon Wilkin. It

discusses the use of topicals to maintain remission:

http://archderm.ama-assn.org/issues/v135n1/fpdf/ded8021.pdf

Again, the derm literature is a bit weird. Only here can someone

(Wilkin) totally trash someone else's study (in this case, Mark Dahl,

who, like Wilkin, is a prominent rosacea researcher an member of the

National cea Society advisory board) in an editorial (as opposed

to letter to the editor), with no opportunity for the criticized

party to respond.

Second, note that Wilkin carefully inquires of his patients which

season is typically " best " for their rosacea (summer seems to be the

most popular choice), and then deliberately starts the remission

program to coincide with what would otherwise be the most benign

period for each patient. Assuming he followed this statitically

biased approach in his 1994 editorial (where he bragged about his

superior success rate in weaning patients off of systemic anitbiotics

to topicals), it certainly raises questions about the conduct of his

studies (and his rather remarkable ego.)

Rick